Patent 7851508 was granted and assigned to RADIX PHARMACEUTICALS, INC. on December, 2010 by the United States Patent and Trademark Office.
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.